Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3921231000168113 | Naltrexone (Apo) (naltrexone hydrochloride 50 mg) tablet, 30 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3921241000168116 | Naltrexone (Apo) 50 mg tablet, 30, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naltrexone (Apo) 50 mg tablet, 30, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet, 30, bottle | Is a | Naltrexone (Apo) 50 mg tablet, 30 | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet, 30, bottle | has TPUU | Naltrexone (Apo) 50 mg tablet | true | Inferred relationship | Some | 1 | |
| Naltrexone (Apo) 50 mg tablet, 30, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet, 30, bottle | has TP | Naltrexone (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR